Filing Signals

Source: SEC EDGAR Compiled 2026-09-14 08:28 UTC All 21 checks passing

← All events

Greenwich LifeSciences, Inc.

CIK 1799788 GLSI·Pharmaceutical Preparations · All EDGAR filings ↗

Late filing elevated Filing comparison

Greenwich LifeSciences, Inc. filed its annual report late and said it expects a significant change in results

expects significant change in results Filed on the statutory due date.

(the “Company”) is unable to file its Annual Report on Form 10-K for the fiscal year ended December 31, 2025 (the “Annual Report”) within the prescribed time period without unreasonable effort and expense.
Evidence
Anticipates significant change
Yes
Days past due date
0
Other periodic reports filed
Yes
Routine
No
Severity
elevated
Source
Form 12b-25 (notification of late filing)
Stated reason
(the “Company”) is unable to file its Annual Report on Form 10-K for the fiscal year ended December 31, 2025 (the “Annual Report”) within the prescribed time period without unreasonable effort and expense.
Why
The company told the SEC it could not file a periodic report on time, using Form 12b-25.